Illicit Benzodiazepine Overdose Trends Detected by Toxicology Investigators Consortium (ToxIC)
September 02, 2021 11:49 ET | American College of Medical Toxicology
Phoenix, AZ, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Data gathered by ToxIC’s Fentanyl Analog Study was reported in the CDC’s August 27, 2021 Morbidity and Mortality Weekly Report (MMWR) “Notes from the...
Global Delirium Management Market Is Anticipated Grow at a CAGR of 5.6% from 2021 to 2030
August 02, 2021 06:00 ET | Quince Market Insights
Pune, India, Aug. 02, 2021 (GLOBE NEWSWIRE) -- The global delirium management market is expected to value at USD 352.6 million in 2021 and is expected to grow at a CAGR of 5.6% during the forecast...
RespireRx Pharmaceuticals Inc. Announces $2 Million Funding Commitment Allowing Option Exercise with UWM Research Foundation, Inc. and Entry into a License Agreement for GABA(A) Receptor Allosteric Neuromodulator Intellectual Property
August 04, 2020 08:45 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), has historically been and remains a leader in the research and...